Biomarkers Overview
JH · Effective Oct 1, 2015
35 active Medicare policies list 81522, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J15 · Effective Mar 6, 2018
JJ · Effective Oct 2, 2017
JM · Effective Oct 2, 2017
JE · Effective Jan 30, 2018
4 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 81522 |
|---|---|---|
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of 81522 |
|---|---|---|
| Concert Genetic Testing Oncology: Algorithmic Assays | Not recorded | Referenced |
| Policy | Effective | Status of 81522 |
|---|---|---|
| Gene Expression Profiling for Cancer Indications |
JF · Effective Jan 30, 2018
J5 · Effective Aug 16, 2018
J8 · Effective Aug 16, 2018
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Nov 4, 2021
National · Effective May 8, 2025
J5 · Effective May 1, 2025
National · Effective Jan 22, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
J6 · Effective Jul 15, 2026
| May 1, 2026 |
| Covered with conditions |
| Policy | Effective | Status of 81522 |
|---|---|---|
| Assays of Genetic Expression in Tumore Tissue as a Technique to Determine Breast Cancer Prognosis | Apr 1, 2026 | Covered |